A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...

Medicare will now cover tests that screen for multiple types of cancer at once, under a new bipartisan law backed by Georgia ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...

The Government now has the chance to save countless lives by introducing a targeted screening programme for prostate cancer , the most common cancer among British men.

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...

UK cancer death rates have fallen to a record low after decades of progress, yet deaths from skin, liver and other cancers are quietly climbing.

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with ...

Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, focusing on how contemporary therapeutic choices in metastatic hormone-sensitive ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...